Final published version
Licence: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License
Research output: Contribution to Journal/Magazine › Journal article › peer-review
| <mark>Journal publication date</mark> | 10/2017 |
|---|---|
| <mark>Journal</mark> | Practical Neurology |
| Issue number | 5 |
| Volume | 17 |
| Number of pages | 4 |
| Pages (from-to) | 392-395 |
| Publication Status | Published |
| Early online date | 24/06/17 |
| <mark>Original language</mark> | English |
Cerebral amyloid angiopathy-related inflammation (CAA-I) is a rare variant of cerebral amyloid angiopathy (CAA). Its precise pathophysiology remains uncertain and we currently have limited evidence on which immunosuppressive agents are the most effective in its treatment. The disease course of CAA-I disorders can vary from an isolated clinical event to recurrent episodes. We present a case of biopsy-confirmed CAA-I that gives insight into its potential relapsing nature and the challenges of its long-term management.